ADVANCED STAGE MELANOMAImmunotherapy Study for Patients With Stage IV Melanoma Sponsored by NewLink Genetics Corporation, the main objective of this study is to determine the safety and clinical response rate…

KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA™ KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S. Food and Drug Administration (FDA) has approved KYBELLA™, also known as ATX-101, “for improvement in…

This July 2015 issue of JDD highlights the broad and diverse world of wound healing/care. The manuscripts here in display the breadth of research, management options, and limitations in the…

Clinical Case A 63-year-old white male with diabetes mellitus type II returns to your clinic for follow-up of non-healing neuropathic diabetic foot ulcers. He has not responded to multiple wound…

INTRODUCTION The advent of cosmeceuticals has revolutionized skin care. Dermatologists can now use topically applied compounds to address a variety of skin concerns with the goal of improving the signs…

INTRODUCTION Onychomycosis is a common fungal infection of the nail unit, primarily caused by the dermatophytes Trichophyton rubrum and Trichophyton mentagrophytes,1 that can cause subungual hyperkeratosis, nail plate thickening, and…

INTRODUCTION Zoster vaccine (Zostavax®) is a live attenuated vaccine recommended for healthy adults 60 years or older to reduce the incidence of herpes zoster.1 Patients with autoimmune diseases, such as…

INTRODUCTION Fungal infections caused by dermatophytes, yeasts, and molds occur globally, affecting millions of people. Although the infection can result from contact with an infected animal, soil, or fomites, most…

INTRODUCTION Onychomycosis remains a major clinical and therapeutic challenge for dermatologists, podiatrists, and other healthcare professionals. The disease is difficult to treat effectively and is extremely recalcitrant, but the approach…

INTRODUCTION The condition of the skin on the face deteriorates with age.1 Signs of aging facial skin include: fine lines and wrinkles, reduction in clarity/brightness of the skin, increase in…

INTRODUCTION Psoriasis is a chronic, immune-mediated, inflammatory disorder without precise origin, for which patients are treated with conventional systemic agents and, more recently, biologic agents. The safety of biologic agents…

INTRODUCTION Acute and chronic wounds account for a large number of outpatient and hospital visits in the United States (US). More than 11 million patients are seen annually in an…